Hans Ørskov

13.4k total citations · 2 hit papers
300 papers, 10.9k citations indexed

About

Hans Ørskov is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Physiology. According to data from OpenAlex, Hans Ørskov has authored 300 papers receiving a total of 10.9k indexed citations (citations by other indexed papers that have themselves been cited), including 205 papers in Endocrinology, Diabetes and Metabolism, 67 papers in Molecular Biology and 66 papers in Physiology. Recurrent topics in Hans Ørskov's work include Growth Hormone and Insulin-like Growth Factors (146 papers), Diet and metabolism studies (47 papers) and Metabolism, Diabetes, and Cancer (46 papers). Hans Ørskov is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (146 papers), Diet and metabolism studies (47 papers) and Metabolism, Diabetes, and Cancer (46 papers). Hans Ørskov collaborates with scholars based in Denmark, United Kingdom and United States. Hans Ørskov's co-authors include Jan Frystyk, Jens Otto Lunde Jørgensen, Allan Flyvbjerg, Jens Sandahl Christiansen, J. Weeke, Niels Møller, Bo Dinesen, Casper Skjærbæk, K. G. M. M. Alberti and N. J. Christensen and has published in prestigious journals such as Nature, The Lancet and Circulation.

In The Last Decade

Hans Ørskov

296 papers receiving 10.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Wick Chromatography for Rapid and Reliable Immunoassay of Insulin, Glucagon and Growth Hormone

1968 379 citations Hans Ørskov et al. profile →
INHIBITION OF INSULIN SECRETION BY SOMATOSTATIN

1973 363 citations K. G. M. M. Alberti, Aa. Prange Hansen et al. profile →

Peers

Countries citing papers authored by Hans Ørskov

Since Specialization

Citations

This map shows the geographic impact of Hans Ørskov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Ørskov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Ørskov more than expected).

Fields of papers citing papers by Hans Ørskov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Ørskov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Ørskov. The network helps show where Hans Ørskov may publish in the future.

Co-authorship network of co-authors of Hans Ørskov

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Ørskov. A scholar is included among the top collaborators of Hans Ørskov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Ørskov. Hans Ørskov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cotreatment with Pegvisomant and a Somatostatin Analog (SA) in SA-Responsive Acromegalic Patients 2011 ·The Journal of Clinical Endocrinology & Metabolism ·Michael Madsen, Per Løgstrup Poulsen, Hans Ørskov, Niels Møller, Jens Otto Lunde Jørgensen	43
2	Elevated free IGF2 levels in localized, early-stage breast cancer in women 2008 ·European Journal of Endocrinology ·Ulrick Espelund, Søren Cold, Jan Frystyk, Hans Ørskov, Allan Flyvbjerg	16
3	Gene expression of the GH receptor in subcutaneous and intraabdominal fat in healthy females: relationship to GH-binding protein 2004 ·European Journal of Endocrinology ·Sanne Fisker, B. Hansen, Jens Fuglsang, Kim Kristensen, Per Ovesen, Hans Ørskov, Jens Otto Lunde Jørgensen	28
4	The relationship between the circulating IGF system and the presence of retinopathy in Type 1 diabetic patients 2003 ·Diabetic Medicine ·Jan Frystyk, Toke Bek, Allan Flyvbjerg, (unknown), Hans Ørskov	30
5	Impact of GHBP interference on estimates of GH and GH pharmacokinetics 2002 ·Clinical Endocrinology ·Troels Krarup Hansen, Sanne Fisker, (unknown), (unknown), Jens Sandahl Christiansen, Jens Otto Lunde Jørgensen, Hans Ørskov	38
6	The pharmacokinetics of free insulin-like growth factor-I in healthy subjects 1999 ·Growth Hormone & IGF Research ·Jan Frystyk, Mehboob A. Hussain, Casper Skjærbæk, (unknown), E. R. Froesch, Hans Ørskov	27
7	Developmental Changes in Serum Levels of Free and Total Insulin-Like Growth Factor I (IGF-I), IGF-Binding Protein-1 and -3, and the Acid-Labile Subunit in Rats*This work was supported by grants from the Danish Health Research Council (Grants 9602012 and 9700592), the Aarhus University-Novo Nordisk Center for Research in Growth and Regeneration (Danish Health Research Council Grant 9600822), the Institute of Experimental Clinical Research, University of Aarhus, the Novo Foundation, the Nordic Insulin Foundation, and the National Health and Medical Research Council of Australia (to R.C.B.). 1998 ·Endocrinology* ·Jan Frystyk, Henning Grønbæk, Casper Skjærbæk, Allan Flyvbjerg, Hans Ørskov, Robert C. Baxter	39
8	Effect of immunosuppression on kidney and serum insulin-like growth factor-I (IGF-I), IGF binding proteins, and renal growth following unilateral nephrectomy in rats 1998 ·Metabolism ·Henning Grønbæk, Christian Skjærbæk, Hans Ørskov, (unknown)	8
9	Effect of octreotide, captopril or insulin on renal changes and UAE in long-term experimental diabetes 1998 ·Kidney International ·Henning Grønbæk, Ida Vogel, Ruth Østerby, Ioana Lancranjan, Allan Flyvbjerg, Hans Ørskov	26
10	Sandostatin® LAR®: A promising therapeutic tool in the management of acromegalic patients 1996 ·Metabolism ·Ioana Lancranjan, Christian Bruns, P. Graß, P Jaquet, J Jervell, P. Kendall‐Taylor, S. W. J. Lamberts, Peter Marbach, Hans Ørskov, G. Pagani, Mary N. Sheppard, L Simionescu	119
11	Growth hormone treatment of subfertile males 1996 ·Fertility and Sterility ·Per Ovesen, Jens Otto Lunde Jørgensen, Hans Jakob Ingerslev, Ken K. Y. Ho, Hans Ørskov, Jens Sandahl Christiansen	39
12	Sandostatin LAR®: Pharmacokinetics, pharmacodynamics, efficacy, and tolerability in acromegalic patients 1995 ·Metabolism ·Ioana Lancranjan, Christian Bruns, P. Graß, P Jaquet, J Jervell, P. Kendall‐Taylor, Steven W. J. Lamberts, Peter Marbach, Hans Ørskov, G. Pagani, Mary N. Sheppard, L Simionescu	73
13	Effect of sodium selenite on growth, insulin-like growth factor-binding proteins and insulin-like growth factor-I in rats 1995 ·Journal of Endocrinology ·Henning Grønbæk, Jan Frystyk, Hans Ørskov, Allan Flyvbjerg	38
14	Insulin-like growth factor I (IGF-I) and IGF binding proteins in seminal plasma before and after vasectomy in normal men 1995 ·Fertility and Sterility ·Per Ovesen, Allan Flyvbjerg, Hans Ørskov	23
15	Effect of octreotide on experimental diabetic renal and glomerular growth: importance of early intervention 1995 ·Journal of Endocrinology ·Henning Grønbæk, B Nielsen, Jan Frystyk, Hans Ørskov, Allan Flyvbjerg	15
16	The Role of Plasma Non‐esterified Fatty Acids During Exercise in Type 2 Diabetes Mellitus 1993 ·Diabetic Medicine ·(unknown), Chris Elliott, Brendan Cooper, Jan Reed, Hans Ørskov, K. G. M. M. Alberti, Mark Walker	4
17	Effects of octreotide on insulin-like growth factor I and metabolic indices in growth hormone-treated growth hormone-deficient patients 1993 ·European Journal of Endocrinology ·Torben Laursen, Jens Otto Lunde Jørgensen, Hans Ørskov, Jens Møller, Alan G. Harris, Jens Sandahl Christiansen	5
18	Plasma Arginine-Vasopressin, Renal-Concentrating Ability and Lithium Excretion in a Group of Patients on Long-Term Lithium Treatment 1982 ·The Nephron journals/Nephron journals ·Hans Erik Hansen, E. B. Pedersen, Hans Ørskov, Per Vestergaard, A. Amdisen, Mogens Schou	10
19	Some Actions of Growth Hormone Release Inhibiting Factor 1973 ·BMJ ·Aa. Prange Hansen, Hans Ørskov, K. Seyer‐Hansen, (unknown)	58
20	Plasma Insulin during Remission in Juvenile Diabetes Mellitus 1969 ·BMJ ·K. Johansen, Hans Ørskov	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact